1. Connexin subtype expression during oral carcinogenesis: A pilot study in patients with oral squamous cell carcinoma
    PHILLIPP BROCKMEYER et al, 2016 CrossRef
  2. Impaired gap junctions in human hepatocellular carcinoma limit intrinsic oxaliplatin chemosensitivity: A key role of connexin 26
    YAN YANG et al, 2016 CrossRef
  3. Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections
    María Alejandra Gleisner et al, 2017, Front. Immunol. CrossRef
  4. Multipotency of skeletal muscle stem cells on their native substrate and the expression of Connexin 43 during adoption of adipogenic and osteogenic fate
    Mohamed I. Elashry et al, 2017, Acta Histochemica CrossRef
  5. Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target
    Edward P. Retzbach et al, 2018, Oral Oncology CrossRef
  6. null
    Hong Wan et al, 2018 CrossRef
  7. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells
    Angeliki Asimaki et al, 2016, Circ Arrhythm Electrophysiol CrossRef
  8. Connexin 43 (Cx43) in Cancer: Implications for Therapeutic Approaches via Gap Junctions
    Emily Bonacquisti et al, 2018, Cancer Letters CrossRef
  9. Connexin and pannexin channels in cancer
    Jean X. Jiang et al, 2016, BMC Cell Biol CrossRef
  10. Connexins in cancer: bridging the gap to the clinic
    Trond Aasen et al, 2019, Oncogene CrossRef
  11. TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility
    En-Wei Hsing et al, 2019, PLoS ONE CrossRef
  12. Gap junctions and cancer: communicating for 50 years
    Trond Aasen et al, 2016, Nat Rev Cancer CrossRef
  13. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma
    Heyu Zhang et al, 2015, Tumor Biol. CrossRef
  14. Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
    Cédric Poyet et al, 2015, J Clin Pathol CrossRef
  15. Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature
    Sebastian Blatt et al, 2017, Journal of Cranio-Maxillofacial Surgery CrossRef
  16. miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells
    Jia Ming et al, 2015 CrossRef
  17. The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies
    Bianka Gurbi et al, 2019, Cancers CrossRef
  18. Gap junction-mediated cell-to-cell communication in oral development and oral diseases: a concise review of research progress
    Wenjing Liu et al, 2020, Int J Oral Sci CrossRef
  19. Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43‑mediated gap junction intercellular communication
    Lingzhi Wang et al, 2017, Int J Oncol CrossRef
  20. Connexin 43 reduces susceptibility to sympathetic atrial fibrillation
    Beibei Luo et al, 2018, Int J Mol Med CrossRef
  21. null
    Nagore Del-Río-Ibisate et al, 2020 CrossRef
  22. null
    Mikako Saito, 2020 CrossRef
  23. Ceramide/protein phosphatase 2A axis is engaged in gap junction impairment elicited by PCB153 in liver stem-like progenitor cells
    Roberta Squecco et al, 2021, Mol Cell Biochem CrossRef
  24. Expression of connexin-43 in surgical resections of primary tumor and lymph node metastases of squamous cell carcinoma and adenocarcinoma of the lung: a retrospective study
    Ivana Savic et al, 2022 CrossRef
  25. Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
    Zhao Huang et al, 2022, MedComm CrossRef
  26. Connexins and Glucose Metabolism in Cancer
    Jennifer C. Jones et al, 2022, IJMS CrossRef
  27. Role of gap junctions and connexin 43 in cancerogenesis and tumor metastasis
    Ivana Savić et al, 2022, Medicinski podmladak CrossRef
  28. Connexin 45 is a novel suppressor of melanoma metastasis
    Mikako Saito et al, 2022, Cytotechnology CrossRef
  29. The roles of connexins and gap junctions in the progression of cancer
    Mingming Zhou et al, 2023, Cell Commun Signal CrossRef
  30. Plasma exosome-derived connexin43 as a promising biomarker for melanoma patients
    Yue Shen et al, 2023, BMC Cancer CrossRef
  31. Analysis of connexin 43, connexin 45 and N-cadherin in the human sertoli cell line FS1 and the human seminoma-like cell line TCam-2 in comparison with human testicular biopsies
    Birte Schulz et al, 2023, BMC Cancer CrossRef
  32. Reprogramming of connexin landscape fosters fast gap junction intercellular communication in human papillomavirus-infected epithelia
    Carmen Gallego et al, 2023, Front. Cell. Infect. Microbiol. CrossRef
  33. Pattern Distribution of Connexins in the Ortho- and Parakeratinized Epithelium of the Lingual Mucosa in Birds
    Kinga Skieresz-Szewczyk et al, 2023, Cells CrossRef
  34. A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical Effects
    Roberto Zefferino et al, 2023, Vaccines CrossRef
  35. Connexin-Containing Vesicles for Drug Delivery
    Mahmoud S. Hanafy et al, 2024, AAPS J CrossRef
  36. Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
    Shuo Yu et al, 2024, Cancer Medicine CrossRef